About us
We are a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.
“Who are you working for?”
This is one of the first questions new employees are asked when they start at Bristol Myers Squibb. Because each of our 30,000 colleagues has a loved one either waiting for a necessary medicine or who needed one. Centering ourselves around our “who” is a deeply personal way for each of us to connect to Bristol Myers Squibb's vision of transforming lives through science.
SCIENCE-POWERED
We are motivated by the power of science. BMS is addressing some of the most complex diseases of our time, and our legacy in cancer, HIV and cardiovascular gives us confidence that we will continue rising to each challenge.
PATIENT-CENTRIC
Our global employees keep patients at the heart of everything we do. Giving them hope and delivering life-changing medicines is what inspires us each day.
BUSINESS-DRIVEN
Advancing our business means accelerating solutions for patients and delivering for shareholders. We listen to our partners across healthcare and respond to their needs.
PEOPLE-FOCUSED
Our culture is essential to creating a positive, inclusive environment where employees thrive. Our people share a sense of collective responsibility and work together towards common goals. Led by our passion for patients, we ignite innovation in science and in careers.
About Bristol Myers Squibb Australia
With an Australian presence dating back more than 70 years, Bristol Myers Squibb Australia is a longstanding contributor to Australia’s health and economy.
Some 300 employees are part of the team at BMS Australia, with just over half of the group located at the company’s headquarters in Mulgrave, a suburb of Melbourne.
We play an integral part in Australian clinical research with a local and global impact – currently conducting 100+ trials.
We are an active member of Medicines Australia, the pharmaceutical industry body, and are committed to upholding the Medicines Australia Code of Conduct and maintaining transparency through regular disclosure of information. Our values are rooted in a steadfast commitment to the highest standards of quality, uncompromising ethics, compliance and integrity. They are central to who we are, what we do and how we do it.
Our history
The Bristol Myers Squibb company we know today has a proud heritage involving two companies – Bristol Myers and ER Squibb – that began operating more than 100 years ago.
Based in New York City, USA, the Bristol Myers company began in 1887 when two friends – William McLaren Bristol and John Ripley Myers - founded a small manufacturing company that sold medicines directly to doctors. Even earlier, in 1858, industry pioneer Dr Edward Robinson Squibb formed a pharmaceutical company that would eventually bear his name for years to come, ER Squibb & Sons.
During World War II, both Bristol Myers and Squibb developed manufacturing processes to mass-produce penicillin. In the early 1960s, Bristol Myers developed its first anti-cancer medicine, which is still used for treatment today.
In 1989, Squibb and Bristol Myers merged, forming the modern company that is now known as Bristol Myers Squibb.
In Australia during 1967, the Prime Minister Rt. Hon. Harold Holt officially opened the company’s manufacturing plant in the Melbourne suburb of Noble Park (known then as E.R Squibb and Sons Pty Ltd). The Australian company remained at this site until 2012, when the business shifted its headquarters to the current Mulgrave location.
